After leaving Tianya Jewelry Store, Su Zhe received a call again, which was from Li Changhua.

Li Changhua informed Su Zhe that Changhua Pharmaceutical's funds were now in place and could be transferred to his account immediately.

In addition to this news, Li Changhua has another piece of good news to tell Su Zhe.

That is the clinical trial of the blue elixir, and now it is over, and the results of this last clinical trial are all very perfect, far beyond the original plan.

After the clinical trial of the blue elixir is over, it will not be long before the approval of the Food and Drug Administration will come down, so the blue elixir will soon be officially put into production.

This is definitely good news for Changhua Pharmaceutical, and Su Zhe is also very happy about it.

Su Zhe didn't expect that today's surprises would come one after another, and there would be so much good news today.

First of all, Tianya Jewelry Store raised enough funds in two days to settle the balance of the transaction, which made Su Zhe very happy.

Unexpectedly, Changhua Pharmaceutical also prepared 500 million yuan in cash for Su Zhe today, and it could be in place immediately.

The most important thing is that even the clinical trial of the blue elixir is perfect today, and the approval of the Food and Drug Administration will follow, which is very important for Changhua Pharmaceutical.

Today's good news is one after another, which makes Su Zhe a little overwhelmed.

Now with Changhua Pharmaceutical's 500 million, Su Zhe has 1.13 billion, and now it is only 370 million less than 1.5 billion, and it is getting closer and closer to the goal.

And because the blue elixir has been clinically tested. also gave Su Zhe a new idea now.

These 370 million. Now Su Zhe has a way to raise it in his heart. Maybe if you succeed, you might get more.

If possible, Su Zhe certainly hopes that he can raise a little more money and acquire more shares, so that he can relieve Yan Yuyan's pressure and let her have more funds to turn around.

Now that the clinical trial of the blue elixir has been successful, this gives Su Zhe the confidence to ask for this blue elixir that has just succeeded. to get a sum of money.

……

Two days later, Su Zhe came to Guanzhou City again.

The reason why Su Zhe came to Guanzhou City today is mainly for two things.

The first thing is that Su Zhe came to Guanzhou Xinjing Pharmaceutical to inspect it, and now all the acquisition procedures have been completed, and now Guanzhou Xinjing Pharmaceutical is a subsidiary of Changhua Pharmaceutical.

Now Guanzhou Xinjing Pharmaceutical and Changhua Pharmaceutical have entered the stage of integration, and once the integration is completed, the blue elixir that is about to be marketed will be produced in Guanzhou Xinjing Pharmaceutical.

This is mainly because of the output of Changhua Pharmaceutical. It has reached its limit, and it is difficult to free up the production line to produce the blue elixir. If you insist on letting Changhua Pharmaceutical produce Blue Elixir, it is also possible, but it is necessary to reduce the output of drugs such as Thawing Ling.

But since Guanzhou Xinjing Pharmaceutical is already a subsidiary of Changhua Pharmaceutical, there is no need to worry so much, as long as Guanzhou Xinjing Pharmaceutical produces Blue Elixir.

And when the output of thawing spirit, sleep pills, and awakening pills needs to be increased, it will also be produced in Guanzhou Xinjing Pharmaceutical.

Because Guanzhou Xinjing Pharmaceutical is generally OEM-based, it rarely produces its own drugs, and most of the OEM agreements between Guanzhou Xinjing Pharmaceutical and other pharmaceutical factories have ended and have not been renewed.

It is also for this reason that Zhan Xin could not continue to maintain Guanzhou Xinjing Pharmaceutical, so he could only choose to be acquired.

However, now that Changhua Pharmaceutical has taken over Guanzhou Xinjing Pharmaceutical, it will naturally no longer do OEM business, and Guanzhou Xinjing Pharmaceutical will only produce its own drugs in the future.

Therefore, because Guanzhou Xinjing Pharmaceutical does not have a major business now, the integration with Changhua Pharmaceutical is very simple, and the process is very smooth, and I believe that it will not take much time to complete the integration and officially merge into Changhua Pharmaceutical.

And Su Zhe came here today to inspect the integration work, which was the first thing he did when he came to Guanzhou City.

However, this matter is only secondary, because the integration work is supervised by Li Changhua throughout the process, and Su Zhe does not need to bother at all, and Su Zhe just stopped by to take a look.

Today, Su Zhe came to Guanzhou City, mainly for the second thing, for the Yadai Group.

Because Yan Yuyan and Shen Chuxia have already contacted Su Zhe, the other shareholders of Yadai Group, and have negotiated with them, and several other shareholders have agreed to sell their shares.

Therefore, Su Zhe came to Guanzhou City today to acquire the shares of Yadai Group.

And the reason why Su Zhe came to buy the shares of Yadai Group today is, of course, because he has raised enough funds, so he came here.

Now Su Zhe's account has 2.63 billion.

Of the 2.63 billion, 500 million is the money for Tianya Jewelry Store to buy jadeite, and 500 million is the payment paid by Changhua Pharmaceutical in advance, and Su Zhe originally had 130 million, which adds up to 1.13 billion.

And the other 1.5 billion was obtained by Su Zhetong Guò Blue Elixir, which really took him a lot of effort.

Two days ago, after the final human clinical trial of the Blue Elixir Tong Guò, Su Zhe began to act.

Su Zhe took the actual report of the blue elixir, as well as the relevant information and documents, came to the bank, and applied for a loan of 1.5 billion yuan, with a term of six months.

And Su Zhe made a mortgage for this is the blue elixir, and used the blue elixir to borrow 1.5 billion from the bank.

If after six months, Su Zhe can't repay the 1.5 billion, then the ownership of the blue elixir will be temporarily owned by the bank, of course, even if Su Zhe can't repay the 1.5 billion, the bank can't affect the production of the blue elixir.

The Blue Elixir will still be produced in the Changhua Pharmaceutical Factory, and the bank will only interfere in the sale of the Blue Elixir.

It's just that the license fee for Changhua Pharmaceutical's production of Blue Elixir will not belong to Su Zhe in the future, but to the bank, and the term is ten years.

At that time, Su Zhe and Changhua Pharmaceutical agreed that for each blue elixir produced, a license fee of one piece needed to be paid.

If Su Zhe is unable to repay the bank's loan within the time limit, then the money will belong to the bank in the past ten years.

With the therapeutic effect of this blue elixir, the future sales will definitely not be low, and the sales volume can be at least more than 2 million pills a day.

If you produce 2 million capsules a day, the license fee will be 2 million, and the production license fee for that year will be 730 million, which means that it only takes 2 years for the bank to recover the loan of 1.5 billion, and the remaining eight years will be a steady profit. (To be continued......)